Overview
HIV Ag/Ab combination immunoassays detect HIV antibodies and HIV-1 p24 antigen to shorten the serologic window relative to antibody-only tests.
Clinical Importance
Screen for HIV infection
Initiate CDC/WHO-aligned laboratory diagnosis algorithms
Specimen Requirements
- Specimen: serum (preferred for most serology/autoimmune immunoassays) or plasma when the method is validated
- Tube: gold/SST (serum separator) or red-top serum; follow method-specific plasma acceptability
- Handling: allow SST to clot fully; centrifuge and separate promptly; avoid repeated freeze–thaw
- Storage: refrigerate short-term; freeze aliquots for delayed testing per manufacturer stability
- Stability: analyte- and kit-specific; do not exceed validated time/temperature limits
Analytical Method
Sandwich/CLIA immunoassays detect antibodies to HIV-1/2 and p24 antigen. Reactive screens require antibody differentiation assay and, when needed, HIV RNA NAT per current algorithm; never diagnose on a single screen.
Instruments Used
Automated analyzers
- Roche Cobas immunoassay systems
- Abbott Alinity / Architect immunoassay systems
- Siemens Healthineers Atellica / ADVIA Centaur systems
- DiaSorin LIAISON systems
- bioMérieux VIDAS systems
- Ortho Vitros immunoassay systems
Manual methods
- Manual ELISA and rapid immunochromatographic serology tests
Reference Values
Assay cutoffs, units, and reference intervals are method- and manufacturer-specific. Always interpret against the performing laboratory report (CLSI EP28-A3c for quantitative intervals where applicable). Serologic patterns require clinical correlation and current guideline algorithms (WHO/CDC/society guidance as adopted locally).
Nonreactive is the expected result in uninfected persons. Reactive results are preliminary until the full algorithm is complete.
Interpretation
Critical and significant-risk immunology/serology findings follow institutional urgent-notification pathways. Confirm the local call list. Textbook examples are not universal thresholds.
Critical values
- Newly confirmed HIV infection typically follows urgent clinical notification pathways
Common Causes of Increased Results
- Reactive screen; proceed to confirmatory/differentiation and NAT steps; do not report as final HIV diagnosis from the screen alone
Common Causes of Decreased Results
- Nonreactive; does not exclude infection during the window period; retest per exposure timing guidance
Clinical Significance
- Routine and risk-based HIV screening
- Diagnostic evaluation of suspected acute/chronic HIV
Factors Affecting Results
Pre-analytical
- Hemolysis, lipemia, or icterus (assay-dependent interference)
- Wrong tube type or incomplete clotting of SST
- Repeated freeze–thaw of serum aliquots
- Testing too early or too late relative to infection/vaccination timing for serology
- Testing during the eclipse/window period
Analytical
- Calibration/QC failure; reagent lot shifts
- Hook effect / antigen excess on selected immunoassays
- Heterophile antibodies, rheumatoid factor, or biotin interference (assay-dependent)
Post-analytical
- Releasing a reactive screen as a confirmed diagnosis
Advantages and Limitations
Advantages
- Detects infection earlier than Ab-only assays
- High throughput screening
Limitations
- Requires algorithm confirmation
- Window period still exists
Clinical Pearls
A reactive HIV Ag/Ab is the start of an algorithm; not the end of the diagnosis.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods (verify current edition). Chapters on clinical immunology and serology.
- Rifai N, Horvath AR, Wittwer CT, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (verify current edition). Immunoassay and protein chapters.
CLSI and Professional Guidelines
- Centers for Disease Control and Prevention. Laboratory testing recommendations for infectious disease serology and related algorithms (verify current CDC guidance for the pathogen).
- Clinical and Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory. CLSI document EP28-A3c (verify current edition).
- Clinical and Laboratory Standards Institute. Immunoassay and related method evaluation documents (e.g., EP05, EP06, EP07, EP17; verify current editions relevant to the assay).
- College of American Pathologists. Accreditation and proficiency testing expectations for immunology/serology (verify current CAP checklist requirements).
- International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Recommendations relevant to protein and immunoassay measurands (verify current IFCC documents).
WHO Publications
- World Health Organization. Laboratory and diagnostic guidance for serologic and immunologic testing (verify current WHO publication for the analyte/assay).
Frequently Asked Questions
Common questions about using this HIV Ag/Ab laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the HIV Ag/Ab laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of HIV Ag/Ab. Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find HIV Ag/Ab specimen requirements?
See the Specimen Requirements section on this page for specimen information related to HIV Ag/Ab. Confirm collection details against your laboratory protocol.
Where are HIV Ag/Ab reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret HIV Ag/Ab results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for HIV Ag/Ab?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from HIV Ag/Ab?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading HIV Ag/Ab?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Immunology & Serology topic.
What are the clinical pearls for HIV Ag/Ab?
See the Clinical Pearls section for concise laboratory practice notes associated with HIV Ag/Ab. Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.
